Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
China Liberal Education Holdings Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement 2023-07-08 05:15
Denali Capital Acquisition Corp. Announces Intention to Extend Deadline to Complete an Initial Business Combination 2023-07-08 04:58
SurplusGLOBAL Showcases Global Parts Platform and Legacy Semiconductor Equipment Solutions at SEMICON WEST 2023 2023-07-07 21:00
Hesai Secures ADAS Lidar Design Win for Multiple New Vehicles with SAIC Motor 2023-07-07 20:30
NaaS Technology Inc. Announces Closing of US$30 Million Private Placement of Convertible Note 2023-07-07 20:00
WiMi Developed An Application Scenario-based Digital Human Gesture Generation Algorithm System 2023-07-07 20:00
Yunji Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement 2023-07-07 18:00
Acer Announces June Consolidated Revenues at NT$26.32 Billion, Up 45.5% Month-on-Month 2023-07-07 17:16
TAL Education Group to Announce First Quarter of Fiscal Year 2024 Financial Results on July 27, 2023 2023-07-07 17:00
CIMC 2022 AGM: Container demand stabilizes and rebounds, Energy new orders surge 2023-07-07 15:08
"Bleach: Brave Souls" 8th Anniversary Bankai Live Airs Tuesday, July 18 2023-07-07 14:10
NOTICE OF ANNUAL GENERAL MEETING 2023-07-07 10:53
China Yuchai Announces Board Change 2023-07-07 10:49
BEST Vietnam and VNPAY Partner to Promote Cashless Payments in Vietnam 2023-07-07 10:31
Addentax Group Corp. Leverages GW Reader Sdn Bhd 's AI Technology to Drive Next-Level Operational Excellence 2023-07-06 21:15
Upcoming WEPACK 2023 to Reveal New Growth Opportunities for the Packaging Industry 2023-07-06 20:39
WiMi to Dig into Interactive Driving Simulation System Using VR Technologies for Intelligent Transportation 2023-07-06 20:00
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris has Completed the Phase III bridging trial Enrollment 2023-07-06 18:33
Queclink Boosts Production Capacity by 30% with New Manufacturing Facility 2023-07-06 14:12
Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China 2023-07-06 10:38
1 405 406 407 408 409 2419